The dopamine hypothesis of schizophrenia primarily attributes which class of symptoms to hyperactivity in mesolimbic dopamine pathways?
Opening subject page...
Loading your content
MCAT Psychological Social Foundations Quiz
Practice 7a Biological Bases Psychological Disorders in MCAT Psychological Social Foundations with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.
Question 1 / 20
0 of 20 answered
The dopamine hypothesis of schizophrenia primarily attributes which class of symptoms to hyperactivity in mesolimbic dopamine pathways?
This quiz focuses on 7a Biological Bases Psychological Disorders, giving you a quick way to practice the rules, question types, and explanations that matter most for MCAT Psychological Social Foundations.
Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.
The dopamine hypothesis of schizophrenia primarily attributes which class of symptoms to hyperactivity in mesolimbic dopamine pathways?
Explanation: The dopamine hypothesis posits that positive symptoms of schizophrenia (e.g., hallucinations, delusions, disorganized thought) are caused by excessive dopaminergic activity in the mesolimbic pathway. In contrast, negative symptoms (e.g., avolition, anhedonia) are thought to be associated with dopamine hypoactivity in the mesocortical pathway.
A researcher proposes that the therapeutic lag of several weeks for selective serotonin reuptake inhibitors (SSRIs) is due to downstream neuroadaptive changes, such as receptor downregulation and increased neurogenesis, rather than an immediate increase in synaptic serotonin. This proposal most directly challenges the assumption that:
Explanation: The therapeutic lag suggests that simply increasing synaptic serotonin is not enough to alleviate depressive symptoms. If it were, SSRIs would work almost immediately. The delay implies that the brain must undergo slower, adaptive changes (like altering receptor density or growing new neurons) in response to the sustained increase in serotonin, and it is these long-term changes that are ultimately responsible for the therapeutic effect. This challenges the idea that the increased serotonin level itself is the direct mechanism of action.
A patient with Parkinson's disease is treated with L-DOPA, a precursor to dopamine. While this alleviates motor symptoms, the patient begins to experience hallucinations and paranoia. This side effect is best explained by:
Explanation: L-DOPA increases dopamine levels throughout the brain. While this is intended to compensate for the dopamine deficiency in the nigrostriatal pathway (improving motor function), it can cause dopamine hyperactivity in other pathways. Overstimulation of the mesolimbic pathway is associated with the positive symptoms of psychosis, such as hallucinations and paranoia, which is what the patient is experiencing.
A physician is treating a patient with bipolar I disorder. Which of the following biological considerations most justifies the use of a mood stabilizer like lithium over an antidepressant alone for long-term management?
Explanation: A primary danger in treating bipolar disorder is that antidepressant medications, when used without a mood stabilizer, can induce a switch from a depressive state into a manic or hypomanic episode. Mood stabilizers like lithium are used to prevent these mood swings in both directions (depressive and manic), providing stability that antidepressants alone cannot and may actively disrupt.
Neuroimaging studies of individuals with obsessive-compulsive disorder (OCD) have most consistently implicated hyperactivity in which of the following neural circuits?
Explanation: The cortico-striato-thalamo-cortical (CSTC) loop is the neural circuit most strongly and consistently associated with the pathophysiology of OCD. This circuit, which includes the orbitofrontal cortex, the striatum (specifically the caudate nucleus), and the thalamus, is thought to be involved in error detection and habit formation. Hyperactivity in this loop is believed to underlie the intrusive thoughts (obsessions) and repetitive behaviors (compulsions) characteristic of OCD.
While both major depressive disorder (MDD) and post-traumatic stress disorder (PTSD) can involve dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, a key distinction often observed in their neuroendocrine profiles is that:
Explanation: This question addresses a nuance in HPA axis dysregulation. While both disorders involve HPA axis changes, a classic finding in a significant subset of individuals with PTSD is enhanced glucocorticoid receptor sensitivity. This leads to a more robust negative feedback signal, which can result in lower baseline levels of circulating cortisol. In contrast, classic melancholic depression is frequently associated with glucocorticoid receptor resistance, impaired negative feedback, and chronically elevated cortisol levels (hypercortisolism).
A person has a specific allele of the serotonin transporter gene (SLC6A4) that confers a higher risk for depression. However, they only develop depression after experiencing a significant life stressor, such as the loss of a job. This scenario is a classic example of:
Explanation: The diathesis-stress model posits that psychopathology is the result of an interaction between a pre-existing vulnerability (the diathesis) and a precipitating event or condition (the stress). In this case, the genetic allele is the diathesis, and the job loss is the stressor. The disorder manifests only when both factors are present.
A new experimental drug, RX-500, is being tested for the treatment of generalized anxiety disorder (GAD). Preclinical studies show that RX-500 acts as a partial agonist at serotonin 5-HT₁ₐ receptors and also blocks norepinephrine reuptake. Researchers hypothesize that the 5-HT₁ₐ agonism will reduce the firing rate of serotonergic neurons in the dorsal raphe nucleus, while the norepinephrine reuptake inhibition will enhance alertness and concentration, which are often impaired in GAD.
Based on the mechanism described, a patient taking RX-500 might be at an increased risk for which of the following side effects, especially at the beginning of treatment?
Explanation: The passage states that RX-500 blocks norepinephrine (NE) reuptake. Increasing the amount of NE in the synapse enhances noradrenergic signaling, which is associated with activation of the sympathetic nervous system. This can lead to side effects such as increased heart rate (tachycardia), increased blood pressure (hypertension), and a state of hyperarousal that can manifest as anxiety or insomnia. Bradycardia (slow heart rate) and sedation are the opposite effects.
A new experimental drug, RX-500, is being tested for the treatment of generalized anxiety disorder (GAD). Preclinical studies show that RX-500 acts as a partial agonist at serotonin 5-HT₁ₐ receptors and also blocks norepinephrine reuptake. Researchers hypothesize that the 5-HT₁ₐ agonism will reduce the firing rate of serotonergic neurons in the dorsal raphe nucleus, while the norepinephrine reuptake inhibition will enhance alertness and concentration, which are often impaired in GAD.
The drug's action as a 5-HT₁ₐ partial agonist is mechanistically similar to which existing class of anxiolytic medication?
Explanation: Buspirone (brand name BuSpar) is an anxiolytic medication whose primary mechanism of action is as a partial agonist at the serotonin 5-HT₁ₐ receptor. This action is distinct from benzodiazepines and barbiturates, which act on the GABA system, and typical antipsychotics, which are primarily dopamine D₂ receptor antagonists.
Research into the neurobiology of borderline personality disorder (BPD) frequently highlights dysregulation in circuits connecting the prefrontal cortex and the amygdala. This finding is most consistent with which core feature of the disorder?
Explanation: The amygdala is a key brain structure for generating emotional responses, particularly negative emotions like fear and anger. The prefrontal cortex exerts top-down control, regulating these emotional responses and inhibiting impulsive behaviors. A dysregulated connection between a hyperactive amygdala and an underactive prefrontal cortex is believed to underlie the intense, rapidly shifting moods (emotional dysregulation) and poor impulse control that are hallmarks of BPD.
A patient treated with a first-generation (typical) antipsychotic develops tardive dyskinesia, characterized by involuntary facial movements. This side effect is thought to result from the long-term blockade of dopamine D₂ receptors leading to:
Explanation: Tardive dyskinesia is a hyperkinetic movement disorder that can arise from chronic treatment with dopamine antagonists. The prevailing theory is that long-term blockade of D₂ receptors in the nigrostriatal pathway (which controls motor function) causes a compensatory change where the postsynaptic neurons increase the number and sensitivity of their D₂ receptors. This state of supersensitivity can lead to excessive dopaminergic signaling and involuntary movements.
The neurogenesis hypothesis of depression suggests that chronic stress suppresses the birth of new neurons, particularly in the hippocampus, and that antidepressant treatments work by reversing this suppression. This hypothesis provides a compelling biological explanation for:
Explanation: Neurogenesis, the process of generating new neurons, is inherently slow, taking place over weeks to months. If a primary mechanism of antidepressant action is to promote neurogenesis and neuronal maturation in the hippocampus, it would take several weeks for these new cells to form, integrate into neural circuits, and exert an effect on mood. This aligns well with the clinical observation that patients typically do not experience significant improvement for 2-4 weeks after starting an antidepressant.
While the biological basis of somatic symptom disorder is not fully understood, some theories propose it involves a dysfunction in how the brain processes and interprets bodily sensations. This suggests an abnormality in the neural processes of:
Explanation: Interoception is the perception of sensations from inside the body (e.g., heartbeat, stomach discomfort). Sensory gating is the neurological process of filtering out redundant or irrelevant stimuli. A dysfunction in these systems could lead an individual to have heightened awareness of normal bodily sensations (poor gating) and to misinterpret them as threatening or indicative of serious illness (abnormal interoception), which are core features of somatic symptom disorder.
A primary neurochemical distinction between Alzheimer's disease and Parkinson's disease is that Alzheimer's is classically associated with a deficit in , while Parkinson's disease is characterized by a deficit in .
Explanation: The pathophysiology of Alzheimer's disease involves the degeneration of cholinergic neurons, particularly in the basal forebrain, leading to a significant deficit in the neurotransmitter acetylcholine, which is crucial for memory and cognitive function. Parkinson's disease is defined by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta, leading to a deficit in dopamine in the basal ganglia, which is responsible for the characteristic motor symptoms.
A patient being treated for depression with a monoamine oxidase inhibitor (MAOI) is accidentally co-prescribed a selective serotonin reuptake inhibitor (SSRI). This combination is highly dangerous because it can lead to:
Explanation: This combination can trigger a life-threatening condition called serotonin syndrome. MAOIs work by preventing the breakdown of monoamines (including serotonin) inside the presynaptic neuron. SSRIs work by blocking the reuptake of serotonin from the synaptic cleft. Using them together causes a massive increase in synaptic serotonin levels, leading to overstimulation of serotonin receptors throughout the brain and body. Symptoms include agitation, confusion, rapid heart rate, high blood pressure, and muscle rigidity.
The neurodevelopmental hypothesis of schizophrenia posits that the illness originates from insults to the brain during prenatal or early postnatal periods. Which of the following pieces of evidence is most consistent with this hypothesis?
Explanation: The neurodevelopmental hypothesis suggests that a brain abnormality is present long before the clinical onset of schizophrenia. Finding structural abnormalities, such as enlarged ventricles, in patients experiencing their first psychotic episode who have never taken antipsychotic medication provides strong support. It indicates the brain changes are not a result of chronic illness or treatment effects, but rather pre-existing factors consistent with a developmental origin.
Which brain structure is considered central to the fear-conditioning process and is often found to be hyperactive in individuals with anxiety disorders?
Explanation: The amygdala, a pair of almond-shaped nuclei in the temporal lobes, is the key brain region for processing fear, learning fear responses (as in classical fear conditioning), and activating other brain regions to produce the physiological and behavioral components of anxiety. Neuroimaging studies consistently show hyperactivity of the amygdala in response to threatening stimuli in patients with various anxiety disorders, including phobias, panic disorder, and PTSD.
The primary neurobiological model for attention-deficit/hyperactivity disorder (ADHD) involves the underactivity of which two neurotransmitter systems, particularly in the prefrontal cortex?
Explanation: The most widely accepted biological model of ADHD centers on the dysregulation of catecholamine neurotransmitters, specifically dopamine and norepinephrine. These pathways, which heavily innervate the prefrontal cortex, are critical for regulating executive functions such as attention, working memory, and impulse control. The efficacy of stimulant medications (e.g., methylphenidate, amphetamine), which act to increase the synaptic availability of dopamine and norepinephrine, provides strong support for this model.
The glutamate hypothesis of schizophrenia gained support from observations that antagonists of the NMDA glutamate receptor, such as phencyclidine (PCP), can induce a state resembling schizophrenia in healthy individuals. This suggests that the pathophysiology of schizophrenia may involve:
Explanation: Since blocking NMDA receptors with drugs like PCP produces schizophrenia-like symptoms, it suggests that the disorder itself might be related to underactivity, or hypofunction, of these same receptors. A leading theory is that NMDA receptor hypofunction on inhibitory GABAergic interneurons leads to a disinhibition of downstream pyramidal neurons, causing dysregulated cortical activity that contributes to positive, negative, and cognitive symptoms.
One of the most consistent structural brain abnormalities found in individuals with chronic schizophrenia is:
Explanation: Enlarged cerebral ventricles (the fluid-filled spaces in the brain) are a well-replicated and robust finding in structural neuroimaging of schizophrenia. This enlargement is thought to be a secondary marker of a reduction in brain tissue volume (atrophy) in adjacent brain regions, particularly in the temporal and frontal lobes.